ImageVerifierCode 换一换
格式:PDF , 页数:3 ,大小:155.76KB ,
资源ID:701614      下载积分:10000 积分
快捷下载
登录下载
邮箱/手机:
温馨提示:
如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
如填写123,账号就是123,密码也是123。
特别说明:
请自助下载,系统不会自动发送文件的哦; 如果您已付费,想二次下载,请登录后访问:我的下载记录
支付方式: 支付宝扫码支付 微信扫码支付   
注意:如需开发票,请勿充值!
验证码:   换一换

加入VIP,免费下载
 

温馨提示:由于个人手机设置不同,如果发现不能下载,请复制以下地址【http://www.mydoc123.com/d-701614.html】到电脑端继续下载(重复下载不扣费)。

已注册用户请登录:
账号:
密码:
验证码:   换一换
  忘记密码?
三方登录: 微信登录  

下载须知

1: 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。
2: 试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。
3: 文件的所有权益归上传用户所有。
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
5. 本站仅提供交流平台,并不能对任何下载内容负责。
6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

版权提示 | 免责声明

本文(DOD A-A-0051775-1986 CLONIDINE HYDROCHLORIDE TABLETS USP《美国专利氯压定氢氯化物药片》.pdf)为本站会员(amazingpat195)主动上传,麦多课文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文库(发送邮件至master@mydoc123.com或直接QQ联系客服),我们立即给予删除!

DOD A-A-0051775-1986 CLONIDINE HYDROCHLORIDE TABLETS USP《美国专利氯压定氢氯化物药片》.pdf

1、-c5-5 A-A-O051775 (DM) 11 December 1986 INTERIM COMMERCIAL ITEM DESCRIPTION CLONIDINE HYDROCHLORIDE TABLETS, USP The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical

2、Materiel, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information. Salient Characteristics: Shall be Clonidine Hydrochloride Tablets, USP. Shall be in accordance with the requirements of the USP. For Strength 1, shall be tablets containing 0.1 m

3、g of Clonidine Hydrochloride per tablet, within the applicable assay limits for the tablets. For Strength 2, shall be tablets containing 0.2 mg of Clonidine Hydrochloride per tablet, within the applicable assay limits for the tablets. For Strength 3, shall be tablets containing 0.3 mg of Clonidine H

4、ydrochloride per tablet, within the applicable assay limits for the tablets. Materials used in the manufacture of the tablets shall be of the highest pharmaceutical grade. WorkmanshiE. The tablets shall be free from defects which detract from their appearance or impair their serviceability. Unit. Fo

5、r Size 1- Bottle (BT). One bottle containing 100 tablets, as specified, constitutes one unit. For Size 2- Bottle (ET). One bottie containing 1000 tablets, as specified, constitutes one unit. AMSC/NA FSC 6505 DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited. O F . THIS

6、 DOCUMENT CONTAINS 3 PAGES. Licensed by Information Handling ServicesI I J A-A-0051775 b5 SSTqFG 0028373 4 A-A-O051775 (DM) For Size 3- Package (PG). One package containing 100 individually sealed tablets (unit dose), as specified, constitutes one unit. Contractor certification. The contractor shall

7、 certify that the product offered meets the salient characteristics of this - description and conforms to the producers own drawings, specifications, standards, and .quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and therea

8、fter as may be otherwise provided for under the provisions of the contract. Regulatory requirements. Federal Food, Druq and Cosmetic Act. If. the product covered by this document has been determined by the U.S. Food and Drug Administration to be under its jurdisdiction, the offeror/contractor shall

9、comply, and be responsible for compliance by its subcontractors/suppliers, with the requirements of the Federal Food, Drug and Cosmetic Act, as amended, and regulations promulgated thereunder. In addition, the offeror/contractor shall comply, and be responsible for compliance by its subcontractors/s

10、uppliers, with the requirements of all other applicable Federal, State, and local statutes, ordinances, and regulations. use recovered material in accordance with Public Law 94-580 to the maximum extent practical. Preservation, packaqinq, p ackinq, labeling, and markinq. Unless othe.rwise specified,

11、 preservation, packaging, and packing shall be to a degree of protection to preclude damage to containers and/or contents thereof under normal shipping conditions, handling, etc:, involving shipment from the supply source to receiving activity, plus reshipment from receiving activity, and shall conf

12、orm to applicable carriers rules and regulations. Intermediate and exterior package quantities and labeling and marking shall be as specified in the contract and/or order. Recovered materials. The offeror/contractor is encouraged to NOTE: The following National Stock Numbers are covered by this docu

13、ment: STRENGTH - SIZE NSN ITEM IDENTIFICATION I 6505-01-005-8425 CLONIDINE HYDROCHLORIDE 2 TABLETS, USP, 0.2 mg, 100s 2 1 Licensed by Information Handling Services- + A-A-0051775 65 W 7777774 0028372 b A-A-O051775 (DM) NSN - 6505-01-024-9879 6505-01-030-1647 6505-01-058-5727 6505-01-101-3729 6505-01

14、-134-8387 6505-01-134-8388 Ordering data package quant the contract ITEM IDENTIFICATION STRENGTH SIZE CLONIDINE HYDROCHLORIDE 2 TABLETS, USP, 0.2 mg, 1000s CLONIDINE HYDROCHLORIDE 1 TABLETS, USP, 0.1 mg, 100s CLONIDINE HYDROCHLORIDE 1 TABLETS, USP, 0.1 mg, 1000s CLONIDINE HYDROCHLORIDE 3 TABLETS, US

15、P, 0.3 mg, 100s CLONIDINE HYDROCHLORIDE 1 TABLETS, USP, 0.1 mg, 100s Individually Sealed, Unit Dose CLONIDINE HYDROCHLORIDE 2 TABLETS, USP, 0.2 mg, 100s Individually Sealed, Unit Dose 2 1 Expiration dating required, intermediate/exterior ities and labeling and marking must be specified in and/or order. MILITARY INTERESTS: PREPARING ACTIVITY: Custodians: DoD - MB Army - MD Navy - MS Air Force - 03 Agent: DLA-DM CIVIL AGENCY COORDINATING ACTIVITIES: VA-OSS PHS FDA-MPQAS PGC 06029 Project No. 6505-2360 3 Licensed by Information Handling Services

copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
备案/许可证编号:苏ICP备17064731号-1